Melatonin—Aluminum Oxide—Polymethylsiloxane Complex on Apoptosis of Liver Cells in a Model of Obesity and Type 2 Diabetes Mellitus
- 作者: Michurina S.1, Ischenko I.1, Arkhipov S.1, Klimontov V.1, Cherepanova M.1, Korolev M.1, Rachkovskaya L.1, Zav’yalov E.2, Konenkov V.1
-
隶属关系:
- Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
- Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science
- 期: 卷 164, 编号 2 (2017)
- 页面: 165-169
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239444
- DOI: https://doi.org/10.1007/s10517-017-3949-x
- ID: 239444
如何引用文章
详细
We studied the effects of a melatonin—aluminum oxide—polymethylsiloxane complex (complex M) on the expression of apoptosis regulators Bcl-2 and Bad in the liver of homozygous db/db BKS.Cg-Dock7m+/+Leprdb/J mice with obesity and type 2 diabetes. Complex M or placebo was administered daily through the gastric tube during weeks 8-16 of life. In mice with type 2 diabetes mellitus receiving placebo, enhanced immunohistochemical reactions for proapoptotic Bad protein and weak response for anti-apoptotic Bcl-2 protein were observed. Administration of complex M shifted the ratio of apoptosis regulators: the area of Bcl-2 expression significantly increased and against the background of reduced Bad expression area. These findings attest to antiapoptotic effect of complex M in the liver on the model of type 2 diabetes mellitus.
作者简介
S. Michurina
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
编辑信件的主要联系方式.
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
I. Ischenko
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
S. Arkhipov
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
V. Klimontov
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
M. Cherepanova
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
M. Korolev
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
L. Rachkovskaya
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
E. Zav’yalov
Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
V. Konenkov
Research Institute of Clinical and Experimental Lymphology, Siberian Division of the Russian Academy of Science
Email: s.michurina@ngs.ru
俄罗斯联邦, Novosibirsk
![](/img/style/loading.gif)